← FDA Drug Approvals (Drugs@FDA)

VRAYLAR

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2015-09-17

Drug application

FDA Application #

NDA204370

Application type

New Drug Application

Brand name

VRAYLAR

Generic name

CARIPRAZINE

Active ingredients

CARIPRAZINE HYDROCHLORIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

Allergan, Inc.

First approval

2015-09-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown